Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid

Journal of Cellular Physiology

Volumn 214, Issue 1, 2008, Pages 201-209

  Rahman, Md Mizanur ^a   Bhattacharya, Arunabh ^a   Fernandes, Gabriel ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; CALCITONIN RECEPTOR; CATHEPSIN K; DOCOSAHEXAENOIC ACID; GELATINASE B; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; TARTARIC ACID; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINE; CELL STRAIN; CELL STRAIN RAW 246.7; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; GENE; MONOCYTE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ACID PHOSPHATASE; ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; DOCOSAHEXAENOIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; EICOSAPENTAENOIC ACID; FATTY ACIDS; ISOENZYMES; LINOLEIC ACID; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OSTEOCLASTS; PROTO-ONCOGENE PROTEINS C-FOS; RANK LIGAND; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 36849030362     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21188     Document Type: Article

References (59)

1. Alexander JW. 1998. Immunonutrition: The role of omega-3 fatty acids. Nutrition 14:627-633.
2. Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A. 2000. Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem 275:4858-4864.
3. Bhattacharya A, Rahman M, Banu J, Lawrence RA, McGuff HS, Garrett IR, Fischbach M, Fernandes G. 2005. Inhibition of osteoporosis in autoimmune disease prone MRL/Mpj-Fas(lpr) mice by n-3 fatty acids. J Am Coll Nutr 24:200-209.
4. Bhattacharya A, Rahman M, Sun D, Fernandes G. 2006. Effect of fish oil on bone mineral density in aging C57BL/6 female mice. J Nutr Biochem 18:372-379.
5. Blok WL, Deslypere JP, Demacker PN, van der Ven-Jongekrijg J, Hectors MP, van der Meer JW, Katan MB. 1997. Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year. Eur J Clin Invest 27:1003-1008.
6. Calder PC. 1998. Immunoregulatory and anti-inflammatory effects of n-3 polyunsaturated fatty acids. Braz J Med Biol Res 31:467-490.
7. Calder PC, Zurier RB. 2001. Polyunsaturated fatty acids and rheumatoid arthritis. Curr Opin Clin Nutr Metab Care 4:115-121.
8. Caughey GE, Mantzioris E, Gibson RA, Cleland LG, James MJ. 1996. The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63:116-122.
9. Chabaud M, Miossec P. 2001. The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model. Arthritis Rheum 44:1293-1303.
10. Connor SL, Connor WE. 1997. Are fish oils beneficial in the prevention and treatment of coronary artery disease? Am J Clin Nutr 66:1020S-1031S.
11. Faccio R, Teitelbaum SL, Fujikawa K, Chappel J, Zallone A, Tybulewicz VL, Ross FP, Swat W. 2005. Vav3 regulates osteoclast function and bone mass. Nat Med 11:284-290.
12. Friedberg CE, Janssen MJ, Heine RJ, Grobbee DE. 1998. Fish oil and glycemic control in diabetes. A meta-analysis. Diabetes Care 21:494-500.
13. Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J. 1994. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis. A 12-month, double-blind, controlled study. Arthritis Rheum 37:824-829.
14. Grimm H, Mayer K, Mayser P, Eigenbrodt E. 2002. Regulatory potential of n-3 fatty acids in immunological and inflammatory processes. Br J Nutr 87:S59-S67.
15. Harris WS. 1997. n-3 fatty acids and serum lipoproteins: Human studies. Am J Clin Nutr 65:1645S-1654S.
16. Heaney RP, Carey R, Harkness L. 2005. Roles of vitamin D, n-3 polyunsaturated fatty acid, and soy isoflavones in bone health. J Am Diet Assoc 105:1700-1702.
17. Hudert CA, Weylandt KH, Lu Y, Wang J, Hong S, Dignass A, Serhan CN, Kang JX. 2006. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci USA 103:11276-11281.
18. Hung P, Kaku S, Yunoki S, Ohkura K, Gu JY, Ikeda I, Sugano M, Yazawa K, Yamada K. 1999. Dietary effect of EPA-rich and DHA-rich fish oils on the immune function of Sprague-Dawley rats. Biosci Biotechnol Biochem 63:135-140.
19. Ikeda F, Nishimura R, Matsubara T, Tanaka S, Inoue J, Reddy SV, Hata K, Yamashita K, Hiraga T, Watanabe T, Kukita T, Yoshioka K, Rao A, Yoneda T. 2004. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest 114:475-484.
20. Indahyani DE, Pudyani PS, Santoso AL, Jonarta AL, Sosroseno W. 2002. The effect of fish oil on bone resorption following pulp exposure in rats. Dent Traumatol 18:206-211.
21. Iotsova V, Caamano J, Loy J, Yang Y, Lewin A, Bravo R. 1997. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappa B2. Nat Med 3:1285-1289.
22. Johnson RS, Spiegelman BM, Papaioannou V. 1992. Pleiotrope effects of a null mutation in the c-fos proto-oncogene. Cell 71:577-586.
23. Kanazawa K, Kudo A. 2005. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis. J Bone Miner Res 20:840-847.
24. Kesavalu L, Vasudevan B, Raghu B, Browning E, Dawson D, Novak JM, Correll MC, Steffen MJ, Bhattacharya A, Fernandes G, Ebersole JL. 2006. Omega-3 fatty acid effect on alveolar bone loss in rats. J Dent Res 85:648-652.
25. Kew S, Mesa MD, Tricon S, Buckley R, Minihane AM, Yaqoob P. 2004. Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on immune cell composition and function in healthy humans. Am J Clin Nutr 79:674-681.
26. Kim YJ, Kim HJ, No JK, Chung HY, Fernandes G. 2006. Anti-inflammatory action of dietary fish oil and calorie restriction. Life Sci 78:2523-2532.
27. Kishida E, Tajiri M, Masuzawa Y. 2006. Docosahexaenoic acid enrichment can reduce L929 cell necrosis induced by tumor necrosis factor. Biochim Biophys Acta 1761:454-462.
28. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T. 2000. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191:275-286.
29. Kobayashi N, Kadono Y, Naito A, Matsumoto K, Yamamoto T, Tanaka S, Inoue J. 2001. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J 20:1271-1280.
30. Kotake S, Kamatani N. 2002. The role of IL-17 in joint destruction. Drug News Perspect 15:17-23.
31. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103:1345-1352.
32. Kruger MC, Horrobin DF. 1997. Calcium metabolism, osteoporosis and essential fatty acids: A review. Prog Lipid Res 36:131-151.
33. Kruger MC, Scholium LM. 2005. Is docosahexaenoic acid more effective than eicosapentaenoic acid for increasing calcium bioavailability? Prostaglandins Leukot Essent Fatty Acids 73:327-334.
34. Kruger MC, Coetzer H, de Winter R, Gericke G, van Papendorp DH. 1998. Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging (Milano) 10:385-394.
35. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL. 2000. TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481-1488.
36. Meydani SN, Endres S, Woods MM, Goldin BR, Soo C, Morrill-Labrode A, Dinarello CA, Gorbach SL. 1991. Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: Comparison between young and older women. J Nutr 121:547-555.
37. Montori VM, Farmer A, Wollan PC, Dinneen SF. 2000. Fish oil supplementation in type 2 diabetes: A quantitative systematic review. Diabetes Care 23:1407-1415.
38. Mori TA, Beilin LJ. 2001. Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction. Curr Opin Lipidol 12:11-17.
39. Mori TA, Bao DQ, Burke V, Puddey IB, Beilin LJ. 1999. Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 34:253-260.
40. Peterson LD, Jeffery NM, Thies F, Sanderson P, Newsholme EA, Calder PC. 1998. Eicosapentaenoic and docosahexaenoic acids alter rat spleen leukocyte fatty acid composition and prostaglandin E2 production but have different effects on lymphocyte functions and cell-mediated immunity. Lipids 33:171-180.
41. Rahman MM, Kukita A, Kukita T, Shobuike T, Nakamura T, Kohashi O. 2003. Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages. Blood 101:3451-3459.
42. Rahman MM, Bhattacharya A, Fernandes G. 2006. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling. J Lipid Res 47:1739-1748.
43. Reinwald S, Li Y, Moriguchi T, Salem N Jr, Watkins BA. 2004. Repletion with (n-3) fatty acids reverses bone structural deficits in (n-3)-deficient rats. J Nutr 134:388-394.
44. Renier G, Skamene E, DeSanctis J, Radzioch D. 1993. Dietary n-3 polyunsaturated fatty acids prevent the development of atherosclerotic lesions in mice. Modulation of macrophage secretory activities. Arterioscler Thromb 13:1515-1524.
45. Robinson DR, Xu LL, Tateno S, Guo M, Colvin RB. 1993. Suppression of autoimmune disease by dietary n-3 fatty acids. J Lipid Res 34:1435-1444.
46. Simopoulos AP. 2002. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 21:495-505.
47. Simopoulos AP, Kifer RR, Wykes AA. 1991. Omega 3 fatty acids: Research advances and support in the field since June 1985 (worldwide). World Rev Nutr Diet 66:51-71.
48. Srivastava S, Toraldo G, Weitzmann MN, Cenci S, Ross FP, Pacifici R. 2001. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. J Biol Chem 276:8836-8840.
49. Sun D, Krishnan A, Zaman K, Lawrence R, Bhattacharya A, Fernandes G. 2003. Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 18:1206-1216.
50. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T. 2002. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3:889-901.
51. Teitelbaum SL. 2000. Bone resorption by osteoclasts. Science 289:1504-1508.
52. Verlengia R, Gorjao R, Kanunfre CC, Bordin S, Martins De Lima T, Martins EF, Curi R. 2004. Comparative effects of eicosapentaenoic acid and docosahexaenoic acid on proliferation, cytokine production, and pleiotropic gene expression in Jurkat cells. J Nutr Biochem 15:657-665.
53. Wang ZQ, Ovitt C, Grigoriadis AE, Mohle-Steinlein U, Ruther U, Wagner EF. 1992. Bone and haematopoietic defects in mice lacking c-fos. Nature 360:741-745.
54. Weldon SM, Mullen AC, Loscher CE, Hurley LA, Roche HM. 2007. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human THP-1 macrophages more effectively than eicosapentaenoic acid. J Nutr Biochem 18:250-258.
55. Xi S, Cohen D, Chen LH. 1998. Effects of fish oil on cytokines and immune functions of mice with murine AIDS. J Lipid Res 39:1677-1687.
56. Yamada Y, Fushimi H, Inoue T, Matsuyama Y, Kameyama M, Minami T, Okazaki Y, Noguchi Y, Kasama T. 1995. Effect of eicosapentaenoic acid and docosahexaenoic acid on diabetic osteopenia. Diabetes Res Clin Pract 30:37-42.
57. Yaqoob P. 2004. Fatty acids and the immune system: From basic science to clinical applications. Proc Nutr Soc 63:89-104.
58. Yaqoob P, Calder P. 1995. Effects of dietary lipid manipulation upon inflammatory mediator production by murine macrophages. Cell Immunol 163:120-128.
59. Yaqoob P, Calder PC. 2003. n-3 polyunsaturated fatty acids and inflammation in the arterial wall. Eur J Med Res 8:337-354.